The patient with recurrent miscarriage

Practitioner

Volumn 246, Issue 1634, 2002, Pages 342-349

  Rutherford, Anthony J ^a   Shillito, Jayne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PREGNANCY; RECURRENT ABORTION; REVIEW; THROMBOPHILIA; UTERUS; VAGINITIS;

ABORTION, HABITUAL; ADULT; ANTIPHOSPHOLIPID SYNDROME; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; THROMBOPHILIA; UTERUS; VAGINOSIS, BACTERIAL;

EID: 0036562148     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stirrat GM. Recurrent miscarriage 1: definition and Epidemiology. Lancet 1990;336:673-675
2. Regan L, Braude P, Trambath P. Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989;299:541-545
3. Stray-Pederson B, Stray-Pederson S. Aetiological factors and subsequent reproductive performance of 195 couples with a prior history of habitual abortion. Am J Obstet Gynaecol 1993;148:140-146
4. Brigham SA, Conlon C, Farquharson RG. Longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999;14:2868-2871
5. Vidal F, Rubio C, Simon C et al. Is there a place for preimplantation genetic diagnosis screening in recurrent miscarriage patients? J Reproduct Fertil 2000;55:143-146
6. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trail of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. BMJ 1997;314:253-257
7. Meinardi JR, Middeldorp S, de Kam PJ et al. Increased risk for fetal loss in carriers of the factor V Leiden mutation. Annals Int Medicine 1999;130:736
8. Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage: a reappraisal. Hum Reprod 2000;15:612-615
9. Clifford K, Rai R, Watson H et al. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 1996;312:1508-1511
10. Llahi-Camp J, Rai R, Ison C et al. Association of bacterial vaginosis with a history of second trimester miscarriage. Hum Reprod 1996;11:1575-1578
11. Ralph SG, Rutherford AJ, Wilson JD. Influence of bacterial vaginosis on conception and miscarriage in the first trimester: a cohort study. BMJ 1999;319:220-223
12. Gibb DMF, Salaria DA. Transabdominal cervicoisthmic cerclage in the management of recurrent second trimester miscarriage and perterm delivery. Br J Obstet Gynaecol 1995;102:802-806
13. Goldstein P, Berrier J, Rosen S et al. A meta-analysis of randomised controlled trails of progestational agents in pregnancy. Br J Obstet Gynaecol 1989;96:265-274
14. Fraser E, Grimes D, Schulz K. Immunisation as therapy for recurrent spontaneous abortion: a review and meta-analysis. Obstet Gynaecol 1993;82:854-859
15. Quenby S, Farquharson RG. Human chorionic gonadotrophin supplementation in recurring pregnancy loss: a controlled trail. Fert Steril 1995;62:708-710
16. Liddell HS, Pattison Ns, Zanderigo A. Recurring miscarriage: outcome after supportive care in early pregnancy. Aust NZ J Obstet Gynaecol 1991;31:320-322